First experiment approved

First Commercial Experiment

For many years, non-target detection experiments have been simulated by using AND/OR bridges or gross delay faults as surrogates. For example, the defective part level can be estimated based upon surrogate detection when test patterns target stuck-at faults in the circuit. For the rst time, test pattern generation techniques that attempt to maximize non-target defect detection have been used to...

The STARTRACK experiment: first measurements

STARTRACK experiment (acronym of STructure of hAdRonic TRACK) aims to measure ionisation cluster distributions in nanometric sites placed at different distances from an accelerated charged particle track. STARTRACK uses a 20 nm wall-less detector [1], already used for studying the nanometric track structure of a Cm alpha particle [2], and then it will use a new detector designed for measuring i...

Roflumilast: first phosphodiesterase 4 inhibitor approved for treatment of COPD

In April 2010, the European Medicines Agency Committee for Medicinal Products for Human Use recommended approval of roflumilast, a selective phosphodiesterase 4 inhibitor, for the "maintenance treatment of severe chronic obstructive pulmonary disease (COPD, FEV(1) postbronchodilator less than 50% predicted) associated with chronic bronchitis in adult patients with a history of frequent exacerba...

Zarxio (Filgrastim-sndz): The First Biosimilar Approved by the FDA.

Zarxio (filgrastim-sndz), a biosimilar for the treatment of severe chronic neutropenia.

The High Current Experiment : First Results